29/09, European Pitch Contest, Pre-Round 2, Cluster „HealthTech & Beyond“, Visionaries Stage
Key Facts
Company Description
arterioscope is a seed-stage B2B software startup and spin-off from TU Graz. We advance cardiovascular health by using AI (machine learning) to determine biomarkers, such as NT-proBNP, digitally and in real time from ECG and PPG data – enabling early-stage diagnostics and continuous monitoring of heart disease in a highly cost-efficient way.
Product/Service Description
Our first product, arterioscope.AI-ECG, is a clinical solution for doctors, OEMs and pharma. It enables patient monitoring and digital biomarker diagnostics, based on standard 12-lead ECG data.
Website
https://arterioscope.com
Crunchbase
Country
Austria
Founding Year
2025
Employees
< 5
Company Stage
MVP/Prototype
Business Model
B2B
Focus Industries
Active Markets
(5 most relevant ones)
Austria, Germany, Switzerland, USA
Look for at Bits & Pretzels
Funding & Investors
3 Lead Investors
Capital Raised to Date
750 000 €
Last Funding Type
Pre-Seed
Last Funding Date
July 2025
Capital Need (€)
< 5M
Currently Fundraising
(at the time of Bits & Pretzels 2025)
Yes
Growth Outlook
Traction
We are currently finalizing our MVP of arterioscope.AI-ECG wich will be available in Q4/2025.
Monetization Model
We will offer arterioscope.AI-ECG to our customers as a MSaaS product.